Pregnant and Nonpregnant Women in Cape Town, South Africa: Drug Use, Sexual Behavior, and the Need for Comprehensive Services by Jones, Hendrée E. et al.
Hindawi Publishing Corporation
International Journal of Pediatrics
Volume 2011, Article ID 353410, 8 pages
doi:10.1155/2011/353410
Research Article
Pregnant and NonpregnantWomen in
Cape Town, South Africa: Drug Use, Sexual Behavior, and
the Need for Comprehensive Services
Hendr´ eeE.Jones,1 FeliciaA.Browne,1 BronwynJ.Myers,2 Tara Carney,2 RachelMiddlesteadt
Ellerson,1 Tracy L. Kline,1 Winona Poulton,1 WilliamA.Zule,1 andWendeeM.Wechsberg1
1Substance Abuse Treatment Evaluations & Interventions Program, RTI International,
3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
2Alcohol and Drug Abuse Research Unit, Medical Research Council, P.O. Box 19070, Tygerberg, Cape Town 7505, South Africa
Correspondence should be addressed to Hendr´ ee E. Jones, hjones@rti.org
Received 30 August 2010; Accepted 9 February 2011
Academic Editor: Lucy Burns
Copyright © 2011 Hendr´ ee E. Jones et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The multiple risks associated with methamphetamine use are of serious concern for women. These risks and consequences are
magniﬁed during pregnancy. This secondary analysis of a parent study compared 26 pregnant to 356 nonpregnant women in
Cape Town, South Africa, on selected demographic, psychosocial, and HIV-risk domains to identify their treatment service
needs. Proportionally, more pregnant than nonpregnant women are using methamphetamine, P = .01, although a very high
rate of women used methamphetamine. Women reported similar monthly rates of sexual intercourse, but pregnant women
were signiﬁcantly less likely to report condom use, P<. 0001, maintaining their risky behavior. Both groups reported
elevated Center for Epidemiological Studies Depression Scale CES-D means, suggesting a need for depression treatment. Results
demonstrate a pervasive need for women’s comprehensive treatment, regardless of pregnancy status. Moreover, ﬁndings support
the urgent need for women-focused and pregnancy-speciﬁc treatment services for methamphetamine use. Finally, a job-skills
training/employment component focus is suggested.
1.Introduction
Cape Town, South Africa is experiencing a devastating level
of methamphetamine use, with an estimated 7% of the adult
population reporting the use of this drug [1, 2] (locally
referred to as “tik”). While methamphetamine use is cause
for concern in both sexes, South African social history
and structure may provide a context that makes women,
especially women of color who live in the township com-
munities, Black (African and Xhosa-speaking) and Coloured
(mixed racial ancestry and Afrikaans-speaking), vulnerable
to intersecting risks [1–4]. If the woman remains untreated
for her methamphetamine use, and then gets pregnant,
the adverse consequences are likely to be exacerbated by
continued drug use.
Not only is dependence a danger for both pregnant
and nonpregnant South African women who use metham-
phetamine, but use also increases risk of exposure to sexual
risk behavior, sexual violence, and HIV, which co-occur with
methamphetamine use [3–7].
Similar to the use of other substances, women typically
begin using methamphetamine before they become preg-
nant. Once pregnant, they are often unable to stop using.
In South Africa, women who live in poor communities
do not usually seek antenatal care, are not very informed
about drug treatment, are afraid of stigma from health
care providers, and are especially vulnerable to drug-related
sexual risk behaviors [7–9]. In addition to the maternal
vulnerabilities associated with methamphetamine misuse,
prenatal stimulant exposure has been associated with full-
termbirthbutsmallgestationalage[10],ariskfactorforlater
developmental problems [11].
In Black and Coloured women in South Africa, the
intersection of drug use, particularly methamphetamine use,
HIV risk behaviors, and unplanned pregnancy must be
addressed to improve the lives of these women and their2 International Journal of Pediatrics
children. Facing a methamphetamine epidemic, Cape Town
is especially challenged with how to best reduce drug use in
childbearing-age women who often do not enter formaldrug
treatment services.
To develop eﬀective women-speciﬁc drug treatment
services designed to meet the particular needs of South
Africanwomen,itisnecessarytoﬁrstexaminethepresenting
issues that pregnant and nonpregnant drug users face.
This secondary analysis of a parent study addresses this
need by examining the baseline characteristics of pregnant
and nonpregnant female drug users who signed informed
consent to participate in an adapted evidence-based women-
focused HIV behavioral intervention: the Western Cape
Women’s Health CoOp. Speciﬁcally, we compared pregnant
and nonpregnant women on a priori selected baseline vari-
ables that were collected as a part of the main study. These
baseline variables encompassed demographic, psychosocial,
and HIV-risk domains to identify their shared and unique
proﬁles of service needs.
2. Methods
2.1. Parent Study. The Western Cape Women’s Health CoOp
is an on-going community-based randomized control trial
in Cape Town, South Africa that compares the eﬀectiveness
of a women-focused HIV behavioral intervention empow-
ering women to reduce substance use, sexual risk, and
victimizationrelativetotwocontrolconditions.TheWestern
Cape Women’s Health CoOp intervention was adapted
from the original North Carolina Women’s CoOp (an HIV
intervention) that focused on empowering women to reduce
their drug use and sexual risk behaviors [12]. The original
Women’s CoOp was culturally adapted for use among
vulnerable sex-trading women in Pretoria, South Africa, to
include a component on drug-related gender-based violence
that focused on addressing sexual risk among vulnerable
South African women [13]. Further changes in Cape Town
for vulnerable women were piloted for group process [4].
2.2. Recruitment. Recruitment for study participation in-
volved outreach that was conducted in targeted communi-
ties, namely, poor, mainly Black and Coloured communities
surrounding the airport in Cape Town. A detailed sampling
plan took into account the number of inhabitants of each
community to help calculate the desired number of women
to be recruited from that community. A targeted sampling
plan was used to balance recruitment communities (i.e.,
outreach zones), and ﬁeld staﬀ worked in pairs to recruit
study participants. Staﬀ canvassed these streets and local
hang-out spots frequented by women who use alcohol and
other drugs and posted ﬂiers and distributed leaﬂets to mar-
ket the study. The ﬁeld staﬀ then approached and engaged
women and verbally requested permission to administer a
brief screening instrument to determine whether they were
eligible to participate in the study. Recruitment began in
September 2008 and ended in January 2011.
2.3. Participants. To be eligible, participants had to provide
informed consent, be female and between the ages of 18 and
33,liveinoneofthetargetcommunities,reportusingatleast
two drugs once per week for the past 3 months, and report
being sexually active with a male partner in the past month.
At the time this smaller secondary study was conducted, a
total of 382 participants were randomized into one of the
study conditions, and their data are included in this analysis.
Based on a pregnancy test administered at study entry, it was
determined that 26 women were pregnant while 356 women
were nonpregnant.
2.4. Measures. The Western Cape Women’s Health CoOp
RevisedRiskBehaviorAssessment(RRBA),adaptedfromthe
RRBA [14] was administered at study entry via computer-
assisted participant interviews. The RRBA has 10 sections
that contain questions about demographics and social char-
acteristics, nutrition/health knowledge, alcohol use, drug
use, drug injecting, sexual behavior, power and empower-
ment, conﬂict and victimization (stigma and vulnerability),
obstetrical/physical/mental health, and HIV. The 20-item
Center for Epidemiological Studies Depression Scale (CES-
D) was used to determine the depressive symptom intensity
experienced by these women [15, 16]. The CES-D also has
been validated in Cape Town, South African women. Scores
range from 0 to 60. A score of 16 in the United States and in
South Africa indicates high risk for clinical depression [16,
17]. Pregnancy and self-reported drug use were conﬁrmed
with urine testing.
2.5. Statistical Analysis. Welch’s t test assuming unequal
population variances and Satterthwaite’s approximation for
degrees of freedom was employed to analyze the continuous
outcome measures. Because the sample sizes in the cells
was disproportionate, and sometimes small for the pregnant
women, the cross-tabulation tables were therefore sparse, so
exact test statistics were used to conduct the goodness-of-ﬁt
tests for the categorical outcomes.
3. Results
3.1. Participant Characteristics. The total sample (Table 1)
was predominantly Coloured (63.6%), in their early 20s,
single, and having completed, on average, less than the 12
years required for graduation from high school. While few of
the women were employed (9.7%), more than three-quarters
indicated that they have skills for employment. They had,
on average, two children living with them. More than 1/3
had spent time in prison. Finally, the elevated mean score
on the CES-D would strongly suggest that a substantial
percentage of these women were currently experiencing
signiﬁcant depressive symptoms.
3.1.1. Alcohol and Drug Use. Table 1 shows that past-month
drug use diﬀered by pregnancy status only for metham-
phetamine (“tik”) use, with a larger proportion of pregnant
than nonpregnant women reporting methamphetamine use
(92.3% versus 66.9%; P = .01). Use of alcohol (91.7%)
and marijuana, or “dagga,” (73.6%) was reported by an
overwhelming majority of both groups. In contrast, bothInternational Journal of Pediatrics 3
Table 1: Demographic and Background Characteristics of Pregnant and Nonpregnant Women (N = 382).
Measure Total sample
(N = 382)
Pregnant women
(n = 26)
Nonpregnant women
(n = 356)
Test statistic (t(df)
or χ2(df)) P
Mean (SD) or n (%) or n/N (%)
Demographics and Social
characteristics
Age 23.1 (4.2) 22.7 (3.6) 24.3 (4.3) t(30) =− 2.22 .03
Race
Black 139 (36.4%) 5 (19.2%) 134 (37.6%) χ2(1) = 3.55 .09
Coloured 243 (63.6%) 21 (80.8%) 222 (62.4%)
Mean years of education
completed 9.3 (1.9) 9.0 (2.2) 9.3 (1.9) t(28) =− 0.69 .49
Marital status
Single 353 (92.4%) 24 (92.3%) 329 (92.4%) χ2(1) = 0.00 1.0
Married 29 (7.6%) 2 (7.7%) 27 (7.6%)
Have a main sexual partner 359 (94.0%) 24 (92.3%) 335 (94.1%) χ2(1) = 0.14 .66
Economic status
Employed 37 (9.7%) 0 (0.0%) 37 (10.4%) χ2(1) = 3.00 .16
Have skills for employment 290 (75.9%) 20 (76.9%) 270 (75.8%) χ2(1) = 0.02 1.0
Mean number of children living
with participant
2.0 (1.7)
(n = 351)
2.1 (1.1)
(n = 17)
2.0 (1.7)
(n = 325) t(20) = 0.05 .96
Legal history
Ever spent time in prison 142 (37.2%) 9 (34.6%) 133 (37.4%) χ2(1) = 0.08 .84
Violence exposure
Ever been physically hurt 171 (44.8%) 8 (30.8%) 163 (45.8%) χ2(1) = 2.21 .16
Ever forced to perform sexual
acts 89 (23.3%) 6 (23.1%) 83 (23.3%) χ2(1) = 0.001 1.0
Risk factors for substance abuse
Depressive symptom severity:
mean CES-D score in past week 28.4 (12.2) 29.7 (9.9) 29.4 (12.2) t(31) = 0.16 .87
Family members use drugs
and/or alcohol too much 289 (75.7%) 22 (84.6%) 267 (75.0%) χ2(1) = 1.22 .35
Maternal history of alcohol use 183 (47.9%) 12 (46.2%) 171 (48.0%) χ2(1) = 0.03 1.0
During the past 30 days, did your
main partner get drunk 211/359 (58.8%) 13/24 (54.2%) 198/335 (59.1%) χ2(1) = 0.23 .67
During the past 30 days, did your
main partner use drugs 232/359 (64.6%) 13/24 (54.2%) 219/335 (65.4%) χ2(1) = 1.23 .28
Alcohol and drug use and drug
injecting
Methamphetamine (tik) use 262 (68.6%) 24 (92.3%) 238 (66.9%) χ2(1) = 7.29 .01
Drink alcohol 341/372 (91.7%) 23/26 (88.5%) 318/346 (91.9%) χ2(1) = 0.38 .47
How often do you drink alcohol (n = 372) (n = 26) (n = 346)
Never 31 (8.3%) 3 (11.5%) 28 (8.1%)
Monthly or less 90 (24.2%) 4 (15.4%) 86 (24.9%)
2–4 times per month 101 (27.2%) 12 (46.2%) 89 (25.7%) χ2(4) = 6.26 .14
2–3 times per week 114 (30.7%) 5 (19.2%) 109 (31.5%)
4 or more times per week 36 (9.7%) 2 (7.7%) 34 (9.8%)
Marijuana (dagga) use 281 (73.6) 17 (65.4%) 264 (74.2%) χ2(1) = 0.96 .36
Rock use 12 (3.1%) 1 (3.8%) 11 (3.1%) χ2(1) = 0.05 .58
Cocaine use 2 (0.5%) 0 (0%) 2 (0.6%) χ2(1) = 0.15 1.04 International Journal of Pediatrics
Table 1: Continued.
Measure Total sample
(N = 382)
Pregnant women
(n = 26)
Nonpregnant women
(n = 356)
Test statistic (t(df)
or χ2(df)) P
Heroin use 13 (3.4%) 0 (0%) 13 (3.7%) χ2(1) = 0.98 1.0
Mandrax (white pipe) use 98 (25.7%) 8 (30.8%) 90 (25.3%) χ2(1) = 0.38 .50
Ever injected 3 (0.8%) 0 (0%) 3 (0.84%) χ2(1) = 0.22 1.0
Participant thinks she has an
alcohol problem 52 (13.6%) 2 (7.7%) 50 (14.0%) χ2(1) = 0.83 .55
Participant thinks she has a drug
problem 244 (63.9%) 16 (61.5%) 228 (64.0%) χ2(1) = 0.07 .83
Drug treatment history
Ever been to drug treatment 34 (8.9%) 3 (11.5%) 31 (8.7%) χ2(1) = 0.24 .72
Reasons for not entering drug
Treatment
Drug treatment does not work 100/348 (28.7%) 7/23 (30.4%) 93/325 (28.6%) χ2(1) = 0.03 .82
Participant does not know where
to go for treatment 95/349 (27.2%) 2/23 (8.7%) 93/326 (28.5%) χ2(1) = 4.27 .05
Lack the money to pay for
treatment 69/349 (19.8%) 2/23 (8.7%) 67/326 (20.6%) χ2(1) = 1.9. 2 8
Nutrition
Frequency of going without food
Never 127 (33.3%) 6 (23.1%) 121 (34.0%)
χ2(3) = 1.36 .64 Less than once a month 87 (22.8%) 7 (26.9%) 80 (22.5%)
Less than once a week 73 (19.1%) 6 (23.1%) 67 (18.8%)
Every week 95 (24.9%) 7 (26.9%) 88 (24.7%)
Obstetrical status
Now pregnant 26 (6.8%)
Seek prenatal care 19 (73.1%)
Received prenatal care 9 (34.6%)
Use of methamphetamine (tik)
while pregnant
Never used 2 (7.7%)
Stopped 0 (0%)
Reduced 16 (61.5%)
Same 7 (26.9%)
Increased 1 (3.9%)
Use of alcohol while pregnant
Never used 2 (7.7%)
Stopped 9 (34.6%)
Reduced 10 (38.5%)
Same 5 (19.2%)
Use of marijuana (dagga) while
pregnant
Never used 5 (19.2%)
Stopped 3 (11.5%)
Reduced 13 (50.0%)
Same 4 (15.4%)
Increased 1 (3.9%)
Notes. Probability values for χ2 tests of signiﬁcance are based on exact methods. Percentages are within their respective sample.International Journal of Pediatrics 5
Table 2: Sexual behavior of pregnant and nonpregnant women (N = 382).
Measure Total sample
(N = 382)
Pregnant women
(n = 26)
Nonpregnant women
(n = 356)
Test statistic (t(df)o r
χ2(df)) P
Last sex was with a man 374 (97.9%) 26 (100%) 348 (97.8%) χ2(1) = 0.60 1.0
At last sex act, participant used
drugs or alcohol use before or
during sex
202 (52.9%) 11 (42.3%) 191 (53.7%) χ2(1) = 1.25 .31
Mean age at ﬁrst vaginal sex 16.2 (2.73) 16.2 (1.63) 16.3 (2.95) t(38) =− 0.19 .85
First vaginal sex was willing 307 (80.4%) 22 (84.6%) 285 (80.1%) χ2(1) = 0.32 .80
Condom used ﬁrst time 117 (30.6%) 12 (46.2%) 105 (29.5%) χ2(1) = 3.17 .08
Past 30 day sex with main
partner 349/359 (97.2%) 24/24 (100%) 325/335 (97.0%) χ2(1) = 0.74 1.0
Mean of sex partners in past 30
days 1.29 (2.0) 1.11 (0.4) 1.36 (2.4) t(199) =− 1.57 .12
Mean times of sex with main
partner in past 30 days 8.09 (6.90) 6.04 (7.96) 8.24 (6.81) t(25) =− 1.29 .25
Mean times of condom use with
sex with main partner in past 30
days
1.93 (4.29) 0.26 (0.92) 2.04 (4.40) t(129) =− 5.75 <.0001
Drugs and alcohol leads to sex
risk 84 (22.0%) 7 (26.9%) 77 (21.6%) χ2(1) = 0.40 .62
Trading sex for money in past 6
months 31/58 (53.5%) 3/5 (60%) 28/53 (52.8%) χ2(1) = 0.09 1.0
Trading sex for drugs in past 6
months 23/58 (39.7%) 1/5 (20.0%) 22/53 (41.5%) χ2(1) = 0.88 .64
Last time had sex:
48 hrs 123 (32.2%) 10 (38.5%) 113 (31.7%)
3–7 days 157 (41.1%) 11 (42.3%) 146 (41.0%) χ2(2) = 0.93 .89
In last 8–30 days 102 (26.7%) 5 (19.2%) 97 (27.3%)
At last sexual encounter the
woman participant was willing 368 (96.3%) 26 (100%) 342 (96.0%) χ2(1) = 1.06 .61
Note. Probability values for χ2 tests of signiﬁcance are based on exact methods.
groups reported infrequent use of most other drugs, includ-
ing heroin and cocaine. Almost two-thirds of the sample
indicated they believed they had a drug problem; only a
small percentage of the sample reported they had an alcohol
problem. These statements appear equally true for both the
pregnant as well as the nonpregnant sample.
3.1.2. Sexual Behavior. Almost all participants had a main
sex partner (Table 1). Table 2 reveals that more than half
the sample had used drugs or alcohol before or during sex,
and that more than half had traded sex for money, and
more than one-third had traded sex for drugs in the past
30 days. The mean number of sex partners in the past 30
days was quite low (1.29 (SD=2.0)), although more than
two-thirds indicated they had engaged in sex with a casual
partner. While over 90% of both groups reported having sex
with their main partner in the past month, pregnant women
reported fewer times of condom use in the past month than
did nonpregnant women (.26 versus 2.04, P<. 0001).
In the pregnant sample, only 34.6% of women received
prenatal care, although 73.1% sought such care (Table 1).
However, it should be noted that a self-report of receipt
of prenatal care could include as little as setting up a
delivery date. More than 50% of the women indicated
that they had reduced or stopped their alcohol, dagga,
and methamphetamine use; however, clinically concerning
percentages of women were still using these substances
during pregnancy (Table 1). This statement is particularly
true for methamphetamine, for which more than 30% of
the pregnant sample reported that their use of metham-
phetamine was the same frequency or more frequent than
before they became pregnant.
3.1.3. Needs Assessment. Table 3 indicates that the most
r e q u e s t e ds e r v i c e si n c l u d e ds e r v i c e si nt h ea r e a so fe m p l o y -
ment (86.7%), ﬁnancial assistance (82.5%), and housing
(68.3%); medical (53.4%), transportation (48.4%), alco-
hol/drug services (47.6%), school (45.8%), and HIV/STD
testing (42.9%) all hover around 50%. Approximately one-
quarter of the sample expressed a need for sexual abuse
and/or legal assistance services. Mental health assistance was
least requested (19.1%). Finally, it should be noted that a
greater proportion of pregnant than nonpregnant women
wanted educational assistance (65.4% versus 44.4%; P =
.04).6 International Journal of Pediatrics
Table 3: Areas in which participants expressed a need for a social service (N = 382).
Measure Total sample
(N = 382)
Pregnant women
(n = 26)
Nonpregnant
women (n = 356) χ2 P
Service area n (%)
Employment 331 (86.7%) 21 (80.8%) 310 (87.1%) 0.83 .37
Financial assistance 315 (82.5%) 19 (73.1%) 296 (83.2%) 1.70 .19
Housing 261 (68.3%) 17 (65.4%) 244 (68.5%) 0.11 .83
Medical 204 (53.4%) 15 (57.7%) 189 (53.1%) 0.21 .69
Transportation 185 (48.4%) 12 (46.2%) 173 (48.6%) 0.06 .84
Alcohol/drug services 182 (47.6%) 10 (38.5%) 172 (48.3%) 0.94 .42
School 175 (45.8%) 17 (65.4%) 158 (44.4%) 4.31 .04
HIV/STD testing 164 (42.9%) 8 (30.8%) 156 (43.8%) 1.68 .22
Child care 113 (29.6%) 7 (26.9%) 106 (29.8%) 0.09 .83
Sexual abuse 99 (25.9%) 4 (15.4%) 95 (26.7%) 1.61 .25
Legal assistance 93 (24.4%) 5 (19.2%) 88 (24.7%) 0.40 .64
Mental health 73 (19.1%) 2 (7.7%) 71 (19.9%) 2.35 .19
Notes. df = 1f o ra l lχ2 tests of signiﬁcance. Probability values are based on exact methods.
4. Discussion
The study has several major ﬁndings. First, there is the
concerning rate of methamphetamine use among pregnant
women compared with nonpregnant women. The fact that
over 90% of the pregnant women reported recently using
methamphetamine is consistent with another recent study
in Cape Town, which showed that among a group of
pregnant women who smoked tobacco, up to 78% reported
methamphetamine use [18]. These results are also consistent
with other reports of high rates of methamphetamine use
observed in Cape Town among the general population,
its women, and its out-of-school young women between
13 to 20 years old [4, 8]. Taken together, the past and
current data highlight the urgent need to develop and
implement eﬀective women-focused interventions to reduce
this epidemic. The high rate of methamphetamine use
among pregnant women may also be a reﬂection of the
relationship between methamphetamine use and sexual risk
behavior, which can result in pregnancy. On a positive note,
themajorityofthepregnantwomenmadeattemptstoreduce
their drug use after learning that they were pregnant, which
is an encouraging sign. However, more than 30% of the
pregnantsampleeitherusedatthesamelevelorincreaseduse
of methamphetamine. Given the potentially adverse impact
of stimulants on fetal brain development, particularly in the
contextofmultipleenvironmentalriskfactors,thereisaclear
need for prevention initiatives in the Western Cape of South
Africa, similar in scope and focus to eﬀorts for informing the
public about fetal alcohol spectrum disorders.
The second major ﬁnding of this secondary analysis is
thepervasiveneedforcomprehensivetreatmentforpregnant
Black and Coloured women in Cape Town, South Africa.
Although these women have myriad needs, the pregnant
women in this sample necessarily required medical and
obstetrical care. The literature from South Africa suggests
that over the 16 years since National Health System has
provided free antenatal and intrapartial care to all uninsured
women, many women have not been accessing or have
been underutilizing care before delivery [19]. The reasons
underlying this underutilization are complex and include
structural barriers (e.g., inconvenient hours of clinic opera-
tion,inabilitytotaketimeoﬀfromwork,toolongawaittobe
seen, lack of child care, and/or transportation); relationship
issues(e.g.,unstablerelationshipwiththefatherofthebaby);
psychological factors (e.g., unwanted pregnancy, pregnancy
denial); lack of education as to the need for prenatal health
care; negative interactions with the medical professionals
[20–24]. The current ﬁndings, in context with the prior
literature, suggest that women want medical care as well
as drug and alcohol treatment, yet interventions must be
implemented where they can be reached and at multiple
levels to concurrently address the structural barriers to care,
improve the actual care these women receive, and reduce the
perceived and actual stigma and discrimination the women
feel and encounter.
The third ﬁnding of note is that the pregnant women
had a lower rate of condom use than did the nonpregnant
women. This result suggests that a signiﬁcant proportion
of methamphetamine-using Black and Coloured women
consider condoms to serve the primary role of birth control
rather than of disease prevention. If this conclusion is sup-
ported by future research, community outreach eﬀorts need
to be made to educate this high-risk population regarding
the crucial role that condoms can play in HIV/sexually
transmitted infection prevention.
Finally, it is notable that these women made a clear
distinction between mental health services and alcohol/drug
services. Fewer than 1 in 5 women expressed a need for
mental health services, despite the CES-D mean score being
almost twice that of the clinical cutoﬀ used previously
in low-income US and South African women. Although
increased depressive symptoms are associated with being of
color, lower educational attainment, and low income; havingInternational Journal of Pediatrics 7
substandard living conditions; living in stressful neighbor-
hoods; possibly, lacking support of a partner [17], this
ﬁnding underscores the need for intervention to ameliorate
thesymptomsofdepressionwhileconcurrentlytreatingdrug
addiction.
In contrast to the low self-reported need for mental
health services, almost 1 in 2 women expressed a need for
alcohol/drug services. Moreover, the most pressing needs
expressed were for economic support, with more than three-
quarters of the women wanting employment and ﬁnancial
aid; housing only slightly trailed the former two needs. These
conclusions appear to be equally valid for the pregnant
women as for the nonpregnant women.
5. Study Limitations
As with all studies, the present study has its limitations. First,
it involved a preliminary and secondary analysis to the aims
from ongoing larger Western Cape Women’s Health CoOp
project,whichhasafocusonHIVpreventionthatisdiﬀerent
from the present project. Thus, the inclusion and exclusion
criteria of the parent project may have adversely impacted
the ability to recruit a representative sample of Black and
Coloured South African women. Second, the extent to which
these results generalize to the larger population of Black
and Coloured South African women is unknown. Third,
because the primary focus of the parent project was not
pregnancy and substance use, the number of respondents
who were pregnant was relatively low in comparison to
the size of the nonpregnant sample. Fourth, the RRBA was
focused on collecting a wide variety of information, not
all of which was maximally relevant to pregnant women.
Despite the limitations, the ﬁndings provide considerable
initial information on the similarities and unique issues
for pregnant and nonpregnant Black and Coloured South
African women.
6. Conclusions
Study ﬁndings strongly support two conclusions. First, the
widespread use of methamphetamine in pregnant Black and
Coloured South African women indicate an urgent need
for the development and implementation of comprehensive
treatment programs to address methamphetamine use (as
well as other co-occurring substance use) in these women.
Second, ﬁndings suggest that both common and unique
issues between pregnant and nonpregnant women must be
addressed when developing and adapting comprehensive
treatments for substance-using Black and Coloured South
African women of childbearing age. Notably, the dismal
circumstances that impact the health and well-being of many
of these women (and their children) are unlikely to change
until they are provided with women-centered medical and
obstetrical care and drug treatment. Moreover, programs
should include employment or job-skills training so that
these women can break the cycle of trading sex for money
and drugs.
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